Literature DB >> 16306225

CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation.

Valérie Capra1, Saula Ravasi, Maria Rosa Accomazzo, Simona Citro, Monica Grimoldi, Maria P Abbracchio, G Enrico Rovati.   

Abstract

Both cysteinyl-leukotrienes and extracellular nucleotides mediate inflammatory responses via specific G-protein-coupled receptors, the CysLT and the P2Y receptors, respectively. Since these mediators accumulate at sites of inflammation, and inflammatory cells express both classes of receptors, their responses are likely to be crossregulated. We investigated the molecular basis of desensitization and trafficking of the CysLT1 receptor constitutively and transiently expressed in the human monocyte/macrophage-like U937 or COS-7 cells in response to LTD4 or nucleotides. Exposure to agonist induced a rapid homologous desensitization of the CysLT1 receptor [as measured by the reduction in the maximal agonist-induced intracellular cytosolic Ca2+ ([Ca2+]i) transient], followed by receptor internalization (as assessed by equilibrium binding and confocal microscopy). Activation of P2Y receptors with ATP or UDP induced heterologous desensitization of the CysLT1 receptor. Conversely, LTD4-induced CysLT1 receptor activation had no effect on P2Y receptor responses, which suggests that the latter have a hierarchy in producing desensitizing signals. Furthermore, ATP/UDP-induced CysLT1 receptor desensitization was unable to cause receptor internalization, induced a faster recovery of CysLT1 functionality and was dependent upon protein kinase C. By contrast, homologous desensitization, which is probably dependent upon G-protein-receptor kinase 2 activation, induced a fast receptor downregulation and, accordingly, a slower recovery of CysLT1 functionality. Hence, CysLT1 receptor desensitization and trafficking are differentially regulated by the CysLT1 cognate ligand or by extracellular nucleotides. This crosstalk may have a profound physiological implication in the regulation of responses at sites of inflammation, and may represent just an example of a feedback mechanism used by cells to fine-tune their responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306225     DOI: 10.1242/jcs.02668

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  26 in total

1.  Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation.

Authors:  Marta Fumagalli; Simona Daniele; Davide Lecca; Philip R Lee; Chiara Parravicini; R Douglas Fields; Patrizia Rosa; Flavia Antonucci; Claudia Verderio; M Letizia Trincavelli; Placido Bramanti; Claudia Martini; Maria P Abbracchio
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 2.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.

Authors:  Paolo Ciana; Marta Fumagalli; Maria Letizia Trincavelli; Claudia Verderio; Patrizia Rosa; Davide Lecca; Silvia Ferrario; Chiara Parravicini; Valérie Capra; Paolo Gelosa; Uliano Guerrini; Silvia Belcredito; Mauro Cimino; Luigi Sironi; Elena Tremoli; G Enrico Rovati; Claudia Martini; Maria P Abbracchio
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

Review 4.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

5.  The purinergic G protein-coupled receptor 6 inhibits effector T cell activation in allergic pulmonary inflammation.

Authors:  Giorgio Giannattasio; Shin Ohta; Joshua R Boyce; Wei Xing; Barbara Balestrieri; Joshua A Boyce
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

Review 6.  Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Authors:  Magnus Bäck; William S Powell; Sven-Erik Dahlén; Jeffrey M Drazen; Jilly F Evans; Charles N Serhan; Takao Shimizu; Takehiko Yokomizo; G Enrico Rovati
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

7.  Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.

Authors:  Grzegorz Woszczek; Li-Yuan Chen; Sara Alsaaty; Sahrudaya Nagineni; James H Shelhamer
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

8.  A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes.

Authors:  Valérie Capra; Maria Rosa Accomazzo; Fabrizio Gardoni; Silvia Barbieri; G Enrico Rovati
Journal:  J Lipid Res       Date:  2009-11-15       Impact factor: 5.922

9.  4-thiouridine induces dose-dependent reduction of oedema, leucocyte influx and tumour necrosis factor in lung inflammation.

Authors:  C Evaldsson; I Rydén; A Rosén; S Uppugunduri
Journal:  Clin Exp Immunol       Date:  2008-12-01       Impact factor: 4.330

10.  Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach.

Authors:  Chiara Parravicini; Maria P Abbracchio; Piercarlo Fantucci; Graziella Ranghino
Journal:  BMC Struct Biol       Date:  2010-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.